4.6 Article

Gold Nano/Micro-Islands Overcome the Molecularly Imprinted Polymer Limitations to Achieve Ultrasensitive Protein Detection

期刊

ACS SENSORS
卷 6, 期 3, 页码 797-807

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acssensors.0c01701

关键词

cardiac biomarkers; electrochemical biosensors; heart-fatty acid binding protein (H-FABP); gold nano/micro-islands; molecularly imprinted polymers (MIPs)

资金

  1. Faculty of Engineering at McGill University
  2. Natural Science and Engineering Research Council of Canada (NSERC) [G247765]
  3. Canada Foundation for Innovation (CFI) [G248924]
  4. MI4 (McGill Interdisciplinary Initiative in Infection and Immunity)

向作者/读者索取更多资源

The electrochemical biosensor based on the core-shell structure of gold NMIs and MIP shows high sensitivity, stability, lower detection time and limit in clinical applications compared to traditional methods like ELISA and lateral flow assay rapid test kits.
Here, we report on an electrochemical biosensor based on core-shell structure of gold nano/micro-islands (NMIs) and electropolymerized imprinted ortho-phenylenediamine (o-PD) for detection of heart-fatty acid binding protein (H-FABP). The shape and distribution of NMIs (the core) were tuned by controlled electrodeposition of gold on a thin layer of electrochemically reduced graphene oxide (ERGO). NMIs feature a large active surface area to achieve a low detection limit (2.29 fg mL(-1), a sensitivity of 1.34 x 10(13) mu A mM(-1)) and a wide linear range of detection (1 fg mL(-1) to 100 ng mL(-1)) in PBS. Facile template H-FABP removal from the layer (the shell) in less than 1 min, high specificity against interference from myoglobin and troponin T, great stability at ambient temperature, and rapidity in detection of H-FABP (approximately 30 s) are other advantages of this biomimetic biosensor. The electrochemical measurements in human serum, human plasma, and bovine serum showed acceptable recovery (between 91.1 +/- 1.7 and 112.9 +/- 2.1%) in comparison with the ELISA method. Moreover, the performance of the biosensor in clinical serum showed lower detection time and limit of detection against lateral flow assay (LFA) rapid test kits, as a reference method. Ultimately, the proposed biosensor based on the core-shell structure of gold NMIs and MIP opens interesting avenues in the detection of proteins with low cost, high sensitivity and significantstability for clinical applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据